Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage
Starting soon · Phase 3 · Has a placebo group
Conditions studied: Intracerebral Haemorrhage
In brief
BEAT ICH will be a pragmatic, randomised, placebo-controlled, blinded, superiority clinical trial aiming to recruit 5676 patients aged ≥18 years who survive ICH and assign them 1:1 to starting antiplatelet monotherapy (Aspirin 75 mg od) versus placebo for the entire duration of the trial for preventing MACE. Recruitment duration is for 2.5 years. The duration of the medication and follow-up will vary based on recruitment timeline. If recruited during the first year of the trial, the patient will take the medication for three years or until the trial ends or an event occurs, with a matching follow-up period. If recruited towards the end of the trial, he/she will take the medication for six months and be followed up for the same duration. The trial's follow-up duration is three years. The patients will be recruited for 2.5 years, and the last recruit will have a minimum follow-up of six months. No new patients will be recruited within the last six months of the trial, but all the patients will be followed up until the end of the trial.
Key facts
- Study ID
- NCT07243704
- Run by
- Christian Medical College and Hospital, Ludhiana, India
- People needed
- 5676
- Starts
- 2026-02-15
- Expected to finish
- 2029-02-14
- Last updated by the study team
- 2026-02-09
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- First-ever Intracerebral Haemorrhage
- Presenting ≥24 hrs up to 3 months of stroke symptoms confirmed by brain imaging
- CT /MRI confirming Intracerebral Haemorrhage
- Alive ≥24 hours after non-traumatic ICH
You may not qualify if…
- ICH is known to be due to trauma, a structural cause (e.g., aneurysm, arteriovenous malformation, cerebral cavernous malformation, venous thrombosis, or tumour), or haemorrhagic transformation of cerebral infarction
- Glasgow coma score ≤5
- Taking any antiplatelet or anticoagulant therapy 15 days prior to randomization.
- Women pregnant, breastfeeding, childbearing potential, and not using contraceptives
- Enrolled in any other clinical trial
- Sick or compromised patients with life expectancy of less than a year
- Geographical or other factors that prohibit long-term follow-up
Where it is running
- Government Medical College — Anantnag, Jammu and Kashmir, India
- Shri Maharaja Hari Singh (SMHS) Hospital — Srinagar, Jammu and Kashmir, India
- Rajendra Institute of Medical Sciences — Ranchi, Jharkhand, India
- KLE's Dr. Prabhakar Kore Hospital & Medical Research Centre — Belagavi, Karnataka, India
- Kasturba Medical College Manipal — Manipal, Karnataka, India
- Amrita Institute for Medical Sciences and Research Center — Kochi, Kerala, India
- Government Medical College Trivandrum — Thiruvananthapuram, Kerala, India
- Sree Chitra Tirunal Institute for Medical Sciences and Technology — Thiruvananthapuram, Kerala, India
- P. D. Hinduja Hospital and Medical Research Centre — Mumbai, Maharashtra, India
- Sahyadri Superspeciality Hospital — Nashik, Maharashtra, India
- Bharati Vidyapeeth DTU Medical College — Pune, Maharashtra, India
- Institute of Human Behaviour and Allied Sciences — New Delhi, National Capital Territory of Delhi, India
- All India Institute of Medical Sciences — Bhubaneswar, Odisha, India
- Guru Gobind Singh Medical College and Hospital — Farīdkot, Punjab, India
- PBM Hospital — Bikaner, Rajasthan, India
- Santokba Durlabhji Memorial Hospital — Jaipur, Rajasthan, India
- Jaiswal Hospital and Neuro Institute — Kota, Rajasthan, India
- KG Hospital and Post Graduate Medical Institute Coimbatore — Coimbatore, Tamil Nadu, India
- Tirunelveli Medical College — Tirunelveli, Tamil Nadu, India
- Christian Medical College Vellore — Vellore, Tamil Nadu, India
- King George's Medical University — Lucknow, Uttar Pradesh, India
- All India Institute of Medical Sciences — Raebareli, Uttar Pradesh, India
- Institute of Medical Sciences of the Banaras Hindu University (BHU) — Varanasi, Uttar Pradesh, India
- Bangur Institute of Neurosciences — Kolkata, West Bengal, India
- St Stephen's Hospital — Delhi, India
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.